Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Narrow-spectrum antibiotic that treats C. difficile colitis. | Hospital antibiotic for MRSA and C. difficile. |
| Body system | Antibiotics | Antibiotics |
| Drug class | Gut-acting antibiotics | Glycopeptides |
| Supply | Prescription only | Prescription onlyWHO essential medicine |
| Main uses | C. difficile infection | MRSA infections, Sepsis with resistant bacteria, Endocarditis, C. difficile colitis (oral), Meningitis (with other drugs) |
| How it works | Kills C. difficile in the gut with little effect on healthy bacteria. | Grabs the building blocks of the bacterial wall so they can't link up. |
| Starts working | Within days | — |
| Half-life | About 8–10 hours | 4–6 hours (longer in kidney disease) |
| Typical adult dose | 200 mg twice a day for 10 days. | IV: weight-based, adjusted to blood levels. C. difficile: 125 mg by mouth four times a day for 10 days. |
| Forms | Tablet | IV infusion, Capsule, Oral solution |
| Common side effects | Nausea, Vomiting, Constipation, Abdominal pain | Flushing and itching if infused too fast, Rash, Nausea |
| Serious side effects | Allergic reactions, Low blood counts (rare) | Kidney injury, Hearing damage, Low white cells |
| Don't take if | Allergy to macrolides (rarely cross-reactive) | — |
| Alcohol | Usually no problem in moderation. No direct interaction. | — |
| Pregnancy | Use with cautionLimited data; avoid unless needed. | Use with cautionUsed when needed; levels monitored. |
| Breastfeeding | Use with cautionUnknown amounts in milk. | — |
| In use since | — | 1958 |
| Brand names | United States: DificidUnited Kingdom: DificlirIndia: Fidaxomicin (generic) | United States: Vancocin, FirvanqUnited Kingdom: Vancocin |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | A07AA12 | J01XA01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker